Literature DB >> 24996170

Modeling a genetic risk for schizophrenia in iPSCs and mice reveals neural stem cell deficits associated with adherens junctions and polarity.

Ki-Jun Yoon1, Ha Nam Nguyen2, Gianluca Ursini3, Fengyu Zhang3, Nam-Shik Kim1, Zhexing Wen1, Georgia Makri1, David Nauen4, Joo Heon Shin3, Youngbin Park5, Raeeun Chung5, Eva Pekle5, Ce Zhang1, Maxwell Towe5, Syed Mohammed Qasim Hussaini5, Yohan Lee6, Dan Rujescu7, David St Clair8, Joel E Kleinman3, Thomas M Hyde3, Gregory Krauss9, Kimberly M Christian1, Judith L Rapoport6, Daniel R Weinberger10, Hongjun Song11, Guo-Li Ming12.   

Abstract

Defects in brain development are believed to contribute toward the onset of neuropsychiatric disorders, but identifying specific underlying mechanisms has proven difficult. Here, we took a multifaceted approach to investigate why 15q11.2 copy number variants are prominent risk factors for schizophrenia and autism. First, we show that human iPSC-derived neural progenitors carrying 15q11.2 microdeletion exhibit deficits in adherens junctions and apical polarity. This results from haploinsufficiency of CYFIP1, a gene within 15q11.2 that encodes a subunit of the WAVE complex, which regulates cytoskeletal dynamics. In developing mouse cortex, deficiency in CYFIP1 and WAVE signaling similarly affects radial glial cells, leading to their ectopic localization outside of the ventricular zone. Finally, targeted human genetic association analyses revealed an epistatic interaction between CYFIP1 and WAVE signaling mediator ACTR2 and risk for schizophrenia. Our findings provide insight into how CYFIP1 regulates neural stem cell function and may contribute to the susceptibility of neuropsychiatric disorders.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24996170      PMCID: PMC4237009          DOI: 10.1016/j.stem.2014.05.003

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN: 1875-9777            Impact factor:   24.633


  47 in total

1.  WAVE2 is required for directed cell migration and cardiovascular development.

Authors:  Daisuke Yamazaki; Shiro Suetsugu; Hiroaki Miki; Yuki Kataoka; Shin-Ichi Nishikawa; Takashi Fujiwara; Nobuaki Yoshida; Tadaomi Takenawa
Journal:  Nature       Date:  2003-07-24       Impact factor: 49.962

Review 2.  CNVs: harbingers of a rare variant revolution in psychiatric genetics.

Authors:  Dheeraj Malhotra; Jonathan Sebat
Journal:  Cell       Date:  2012-03-16       Impact factor: 41.582

3.  Pax6, Tbr2, and Tbr1 are expressed sequentially by radial glia, intermediate progenitor cells, and postmitotic neurons in developing neocortex.

Authors:  Chris Englund; Andy Fink; Charmaine Lau; Diane Pham; Ray A M Daza; Alessandro Bulfone; Tom Kowalczyk; Robert F Hevner
Journal:  J Neurosci       Date:  2005-01-05       Impact factor: 6.167

Review 4.  Neurodevelopmental abnormalities in schizophrenia: insights from neuropathology.

Authors:  S E Arnold
Journal:  Dev Psychopathol       Date:  1999

5.  Rare chromosomal deletions and duplications increase risk of schizophrenia.

Authors: 
Journal:  Nature       Date:  2008-07-30       Impact factor: 49.962

Review 6.  The glial nature of embryonic and adult neural stem cells.

Authors:  Arnold Kriegstein; Arturo Alvarez-Buylla
Journal:  Annu Rev Neurosci       Date:  2009       Impact factor: 12.449

7.  The fragile X syndrome protein represses activity-dependent translation through CYFIP1, a new 4E-BP.

Authors:  Ilaria Napoli; Valentina Mercaldo; Pietro Pilo Boyl; Boris Eleuteri; Francesca Zalfa; Silvia De Rubeis; Daniele Di Marino; Evita Mohr; Marzia Massimi; Mattia Falconi; Walter Witke; Mauro Costa-Mattioli; Nahum Sonenberg; Tilmann Achsel; Claudia Bagni
Journal:  Cell       Date:  2008-09-19       Impact factor: 41.582

8.  Confirmed rare copy number variants implicate novel genes in schizophrenia.

Authors:  Gloria W C Tam; Louie N van de Lagemaat; Richard Redon; Karen E Strathdee; Mike D R Croning; Mary P Malloy; Walter J Muir; Ben S Pickard; Ian J Deary; Douglas H R Blackwood; Nigel P Carter; Seth G N Grant
Journal:  Biochem Soc Trans       Date:  2010-04       Impact factor: 5.407

9.  Large recurrent microdeletions associated with schizophrenia.

Authors:  Hreinn Stefansson; Dan Rujescu; Sven Cichon; Olli P H Pietiläinen; Andres Ingason; Stacy Steinberg; Ragnheidur Fossdal; Engilbert Sigurdsson; Thordur Sigmundsson; Jacobine E Buizer-Voskamp; Thomas Hansen; Klaus D Jakobsen; Pierandrea Muglia; Clyde Francks; Paul M Matthews; Arnaldur Gylfason; Bjarni V Halldorsson; Daniel Gudbjartsson; Thorgeir E Thorgeirsson; Asgeir Sigurdsson; Adalbjorg Jonasdottir; Aslaug Jonasdottir; Asgeir Bjornsson; Sigurborg Mattiasdottir; Thorarinn Blondal; Magnus Haraldsson; Brynja B Magnusdottir; Ina Giegling; Hans-Jürgen Möller; Annette Hartmann; Kevin V Shianna; Dongliang Ge; Anna C Need; Caroline Crombie; Gillian Fraser; Nicholas Walker; Jouko Lonnqvist; Jaana Suvisaari; Annamarie Tuulio-Henriksson; Tiina Paunio; Timi Toulopoulou; Elvira Bramon; Marta Di Forti; Robin Murray; Mirella Ruggeri; Evangelos Vassos; Sarah Tosato; Muriel Walshe; Tao Li; Catalina Vasilescu; Thomas W Mühleisen; August G Wang; Henrik Ullum; Srdjan Djurovic; Ingrid Melle; Jes Olesen; Lambertus A Kiemeney; Barbara Franke; Chiara Sabatti; Nelson B Freimer; Jeffrey R Gulcher; Unnur Thorsteinsdottir; Augustine Kong; Ole A Andreassen; Roel A Ophoff; Alexander Georgi; Marcella Rietschel; Thomas Werge; Hannes Petursson; David B Goldstein; Markus M Nöthen; Leena Peltonen; David A Collier; David St Clair; Kari Stefansson
Journal:  Nature       Date:  2008-09-11       Impact factor: 49.962

10.  Abnormal intracellular accumulation and extracellular Aβ deposition in idiopathic and Dup15q11.2-q13 autism spectrum disorders.

Authors:  Jerzy Wegiel; Janusz Frackowiak; Bozena Mazur-Kolecka; N Carolyn Schanen; Edwin H Cook; Marian Sigman; W Ted Brown; Izabela Kuchna; Jarek Wegiel; Krzysztof Nowicki; Humi Imaki; Shuang Yong Ma; Abha Chauhan; Ved Chauhan; David L Miller; Pankaj D Mehta; Michael Flory; Ira L Cohen; Eric London; Barry Reisberg; Mony J de Leon; Thomas Wisniewski
Journal:  PLoS One       Date:  2012-05-02       Impact factor: 3.240

View more
  118 in total

Review 1.  Using Patient-Derived Induced Pluripotent Stem Cells to Model and Treat Epilepsies.

Authors:  Xixi Du; Jack M Parent
Journal:  Curr Neurol Neurosci Rep       Date:  2015-10       Impact factor: 5.081

2.  Persistent Cyfip1 Expression Is Required to Maintain the Adult Subventricular Zone Neurogenic Niche.

Authors:  Christa Whelan Habela; Ki-Jun Yoon; Nam-Shik Kim; Arens Taga; Kassidy Bell; Dwight E Bergles; Nicholas J Maragakis; Guo-Li Ming; Hongjun Song
Journal:  J Neurosci       Date:  2020-01-27       Impact factor: 6.167

3.  CNTN5-/+or EHMT2-/+human iPSC-derived neurons from individuals with autism develop hyperactive neuronal networks.

Authors:  Eric Deneault; Muhammad Faheem; Sean H White; Deivid C Rodrigues; Song Sun; Wei Wei; Alina Piekna; Tadeo Thompson; Jennifer L Howe; Leon Chalil; Vickie Kwan; Susan Walker; Peter Pasceri; Frederick P Roth; Ryan Kc Yuen; Karun K Singh; James Ellis; Stephen W Scherer
Journal:  Elife       Date:  2019-02-12       Impact factor: 8.140

4.  Using Induced Pluripotent Stem Cells to Investigate Complex Genetic Psychiatric Disorders.

Authors:  Stephanie J Temme; Brady J Maher; Kimberly M Christian
Journal:  Curr Behav Neurosci Rep       Date:  2016-10-14

Review 5.  Modeling schizophrenia pathogenesis using patient-derived induced pluripotent stem cells (iPSCs).

Authors:  Haneul Noh; Zhicheng Shao; Joseph T Coyle; Sangmi Chung
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-06-28       Impact factor: 5.187

6.  The promises and challenges of human brain organoids as models of neuropsychiatric disease.

Authors:  Giorgia Quadrato; Juliana Brown; Paola Arlotta
Journal:  Nat Med       Date:  2016-10-26       Impact factor: 53.440

7.  HippoCA3mpal Stem Cell Models Expose Dysfunctional Circuits in Schizophrenia.

Authors:  Mandy Johnstone; Rana Fetit
Journal:  Cell Stem Cell       Date:  2018-05-03       Impact factor: 24.633

8.  Altered Expression of ARP2/3 Complex Signaling Pathway Genes in Prefrontal Layer 3 Pyramidal Cells in Schizophrenia.

Authors:  Dibyadeep Datta; Dominique Arion; Kaitlyn M Roman; David W Volk; David A Lewis
Journal:  Am J Psychiatry       Date:  2016-08-13       Impact factor: 18.112

Review 9.  Implications of germline copy-number variations in psychiatric disorders: review of large-scale genetic studies.

Authors:  Masahiro Nakatochi; Itaru Kushima; Norio Ozaki
Journal:  J Hum Genet       Date:  2020-09-21       Impact factor: 3.172

Review 10.  Modeling synaptogenesis in schizophrenia and autism using human iPSC derived neurons.

Authors:  Christa W Habela; Hongjun Song; Guo-Li Ming
Journal:  Mol Cell Neurosci       Date:  2015-12-02       Impact factor: 4.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.